Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Operating Expenses (2023 - 2024)

Historic Operating Expenses for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to $18.3 million.

  • Artiva Biotherapeutics' Operating Expenses rose 2756.28% to $18.3 million in Q4 2024 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year decrease of 7127.29%. This contributed to the annual value of $67.5 million for FY2024, which is 525.22% up from last year.
  • According to the latest figures from Q4 2024, Artiva Biotherapeutics' Operating Expenses is $18.3 million, which was up 2756.28% from $18.3 million recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' Operating Expenses ranged from a high of $18.3 million in Q3 2024 and a low of $14.3 million during Q4 2023